Suzana S Petanceska

Summary

Affiliation: Nathan Kline Institute
Country: USA

Publications

  1. ncbi request reprint Statin therapy for Alzheimer's disease: will it work?
    Suzana S Petanceska
    Nathan S Kline Institute for Psychiatric Research, Dementia Research Group, Orangeburg, NY, 10962, USA
    J Mol Neurosci 19:155-61. 2002
  2. ncbi request reprint Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol
    Suzana S Petanceska
    Center for Dementia Research, Nathan Kline Institute, Orangeburg NY 10962, USA
    J Mol Neurosci 20:395-406. 2003
  3. ncbi request reprint Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits
    Jun Yao
    Department of Psychiatry, New York University, The Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York, USA
    J Neurochem 90:1011-8. 2004
  4. ncbi request reprint Age-associated androgen deficiency and Alzheimer's disease: a case in the making?
    Suzana S Petanceska
    Center for Dementia Research Nathan Kline Institute, Orangeburg, NY 10962, USA
    J Alzheimers Dis 5:271-3. 2003
  5. ncbi request reprint Exploring the links between obesity and Alzheimer's disease
    Suzana S Petanceska
    Curr Alzheimer Res 4:95-6. 2007

Research Grants

  1. Modulation of Alzheimer's Amyloidosis by Statins
    Suzana Petanceska; Fiscal Year: 2004

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Statin therapy for Alzheimer's disease: will it work?
    Suzana S Petanceska
    Nathan S Kline Institute for Psychiatric Research, Dementia Research Group, Orangeburg, NY, 10962, USA
    J Mol Neurosci 19:155-61. 2002
    ..Our results indicate that Lipitor treatment markedly attenuates A beta deposition in this animal model...
  2. ncbi request reprint Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol
    Suzana S Petanceska
    Center for Dementia Research, Nathan Kline Institute, Orangeburg NY 10962, USA
    J Mol Neurosci 20:395-406. 2003
    ..These observations suggest that disrupted cholesterol metabolism may increase the risk of developing AD in part due to the effect of cholesterol on brain ApoE expression...
  3. ncbi request reprint Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits
    Jun Yao
    Department of Psychiatry, New York University, The Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York, USA
    J Neurochem 90:1011-8. 2004
    ....
  4. ncbi request reprint Age-associated androgen deficiency and Alzheimer's disease: a case in the making?
    Suzana S Petanceska
    Center for Dementia Research Nathan Kline Institute, Orangeburg, NY 10962, USA
    J Alzheimers Dis 5:271-3. 2003
  5. ncbi request reprint Exploring the links between obesity and Alzheimer's disease
    Suzana S Petanceska
    Curr Alzheimer Res 4:95-6. 2007

Research Grants2

  1. Modulation of Alzheimer's Amyloidosis by Statins
    Suzana Petanceska; Fiscal Year: 2004
    ....